FDA Investigator Vien Q Le
Vien Q Le has inspections in 6 countries as of 30 Aug 2023. Vien Q Le has collaborated with a combined 2688 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
102
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Viet Nam,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Japan,
Belgium
Co-Investigator(s):
Abby Lmozeke Baker,
Alexandra B Pitkin,
Allen F Hall,
Amy W Yan Mai,
Ana Djurdjevic,
Ana S Cabrera,
Anastasia M Shields,
Anderson,
Annette Melendez,
Anthony N Onianwa,
April P Shaw,
Armando Chavez, MS,
Arsen Karapetyan,
Azza Talaat,
Barbara A Burke,
Benjamin S Liao,
Beverly A Thomas,
Bichsa T Tran,
Bowman,
Brant M Schroeder,
Brentley S Collins,
Brian P Putz,
Bryce A May,
Carol B Czerniak,
Carr Sharpe,
Celeta S Coves,
Charles D Boison,
Charles L Larson,
Comyar Shoghi,
Courtney N Long,
Daniel W Cline,
Darla J Christopher,
Darrin E Davis,
Deborah A Greco,
Decarlos A Gomez,
Dell S Moller,
Diana L Ayala,
Diana M Rand,
Diane Cvan Leeuwen,
Don A Leeseberg,
Donna D Gallien, MPH,
Donna Ltartaglino Besone,
Doretha M Tonkins,
Doretha M Wilson,
Durell L Giles,
Dustin R Abaonza,
Dylan R Jock,
Edwin Melendez,
Emest F Bizjak,
Emily B Camire,
Gabriel M Guevarra,
Gail L Katz,
Garciam,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Gerald Mierle,
Gerald T O'connor,
Grace P Santos,
Greg K Keshishyan,
Helen B Ricalde,
Herminio C Francisco,
Jaclyn N Munsch,
Jacqueline M Bowling,
James C Maclaughlin,
James R Fleckenstein,
Jane Chen,
Janet Pulver,
Jennifer M Foley,
Jeremy H Nguyen,
Jessica B Clark,
Jinkee Mvila Binayug,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Joey V Quitania,
John A Iwen,
John L Stevens,
Joseph J Vannelli,
Juanita Banuelos,
Judy C Nepsa,
Ka L Wong,
Karen J Bak,
Karen L Kosar,
Katherine E Jacobitz,
Kelvin Cheung,
Kenneth S Boehnen,
Lakecha N Lewis,
Laurissa S Flowers,
Laverne Kimble,
Laverne Puckett,
Lawrence H Howell,
Leeterry Moore,
Leonard H Lavi,
Linda S Mattingly,
Lisa Shin,
Luis A Carrion,
Maira P Brading,
Margarita Santiago,
Mary Alice Papdimitriou,
Mary Ewilkerson Brinsko,
Matthew B Casale,
Matthew J Gretkierewicz,
Maxyne T Lam,
Michael D Garcia,
Michael S Araneta,
Miguel A Martinez,
Minh D Phan,
Mizanne E Lewis,
Mpris Inspector,
Mra B Kamberem,
Mra Davism,
Naveen B Walker,
Nianna C Burns,
Nikisha M Bolden,
Olusegun J Ajayi,
Patricia A Mcilroy,
Paul M Chefor,
Phillip L Toy,
Raymond W Brullo,
Richard J Bashay,
Richard W Tubb,
Robert C Hoover,
Robert S Sweeton,
Roger D Gawne,
Ronnie E Jackson,
Rupa Pradhan,
Sandra A Hughes,
Sandra Sejdinovic,
Santos E Camara,
Scott K Zika,
Selene T Torres,
Shaquenta Y Perkins,
Shelley H Beausoleil,
Sonya L Karsik,
State Agency,
Steven E Porter, Jr,
Stewarte,
Susant Hadman,
Taichun Qin, PhD,
Tania L Sawyer,
Tania Y Hall,
Tawny L Colling,
Teena H Aiken,
Terrance L Thomas,
Terri L Jones,
Thanh B Tran,
Thanh M Andrews,
Timothy P Lafave,
Tonia L Sawyer,
Trushani T Desai,
Tuan A Nguyen,
Vanessa R Muller,
Virgilio F Pacio, CSO,
William S Vitale,
Young M Yoon,
Yvette E Guillermo,
Yvette Mlacour Davis,
Yvonne C Wilkes
Vien Q Le's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2000 | EIR | VA GLA Health Care System (WLA) 113 - EIR, 2000-09-08 |
May, 2011 | EIR | Sterling Pharma Solutions Limited - EIR, 2011-05-12 |
December, 2000 | FDA 483 Response | Kingman Hospital Inc - Form 483R, 2001-02-26 |
February, 2002 | FDA 483 Response | Onelegacy-redland - Form 483R, 2002-02-22 |
December, 2000 | EIR | Kingman Hospital Inc - EIR, 2000-12-08 |
January, 2000 | EIR | San Diego Blood Bank - EIR, 2000-01-31 |
February, 2002 | EIR | Onelegacy-redland - EIR, 2002-02-01 |
May, 2000 | EIR | American National Red Cross, The - EIR, 2000-05-16 |
February, 2002 | FDA 483 | INLAND EYE & TISSUE BANK - Form 483, 2002-02-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more